Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation

J Am Coll Cardiol. 2018 Jan 16;71(2):251-252. doi: 10.1016/j.jacc.2017.10.089.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Kidney Injury* / chemically induced
  • Acute Kidney Injury* / prevention & control
  • Aged
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Antithrombins / administration & dosage
  • Antithrombins / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Atrial Fibrillation* / epidemiology
  • Comorbidity
  • Female
  • Humans
  • Kidney Function Tests / methods
  • Male
  • Renal Insufficiency, Chronic* / diagnosis
  • Renal Insufficiency, Chronic* / epidemiology
  • Risk Adjustment / methods
  • Risk Factors
  • Rivaroxaban* / administration & dosage
  • Rivaroxaban* / adverse effects
  • Stroke / etiology
  • Stroke / prevention & control*
  • Treatment Outcome
  • United States / epidemiology
  • Warfarin* / administration & dosage
  • Warfarin* / adverse effects

Substances

  • Anticoagulants
  • Antithrombins
  • Warfarin
  • Rivaroxaban